The rapid rise of a handful of tech firms-the Googles and Facebooks-and other growth stocks has left them in the shade.

少数科技公司的迅速崛起—谷歌和Facebook—以及其他“成长”股让它们黯然失色。

Investors are turning from growth stocks like Tesla to value stocks like commodity producers.

投资者正从特斯拉等成长型股票转向大宗商品生产商等价值型股票。

If you recognize yourself in this description, you might include a couple of heady growth stocks in your portfolio, alongside your more pedestrian investments.

如果你觉得你的情况是这样的话，你可在投资组合中包括几项有令人陶醉的增值前景的增长股，和其他比较平淡的投资项目放在一起。

As interest rates go up, he argues, investors will turn their back on more speculative growth stocks and focus on the quality names in tech.

他认为，随着利率上升，投资者将抛弃更具投机性的成长型股票，转而关注科技股中的优质股。

But not recently. For much of the past decade, value stocks have lagged behind the general market and a long way behind growth stocks, their antithesis.

在过去将近十年时间里，价值股已经落后于共同市场，也远远落后于成长股—它们的对立股票。

Richard Nixon had just won reelection and on Wall Street, traders marked Dow 1,000, with IBM, the growth stock of the day, leading the charge.

理查德·尼克松 (Richard Nixon) 刚刚赢得连任，在华尔街，交易员将道琼斯指数标记为 1, 000 点， 而当时的成长股 IBM 领涨。

Despite last year's plunge, the price-to-earnings ratio for " growth" stocks, those of companies promising big future profits, has fallen back only to where it was in 2019.

尽管去年股价暴跌，但“成长型”股票的市盈率，即那些未来有望获得巨大利润的公司的股票市盈率，也不过是回落到了2019年的水平。

For the past two years the company, which turns 100 in 2023, has traded like a growth stock, doubling in value to $326bn on hopes that overlapping diabetes and obesity drugs could become the biggest-selling class of pharmaceuticals ever.

在过去的两年里， 这家将于 2023 年满 100 岁的公司在交易中表现得像一只成长型股票，市值翻了一番， 达到 3260 亿美元， 原因是希望重叠的糖尿病和肥胖药物能够成为有史以来销量最大的一类药物。